Last updated on August 2020

PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphoma or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)


Find a site near you

Start Over

Sinai Hospital of Baltimore

Baltimore, MD United States
  Connect »

Kaiser Permanente-Oakland

Oakland, CA United States
  Connect »

Ochsner Medical Center Jefferson

New Orleans, LA United States
  Connect »

Children's Hospital of Alabama

Birmingham, AL United States
  Connect »

Arkansas Children's Hospital

Little Rock, AR United States
  Connect »

Children's Hospital Los Angeles

Los Angeles, CA United States
  Connect »

Mattel Children's Hospital UCLA

Los Angeles, CA United States
  Connect »

Yale University

New Haven, CT United States
  Connect »

Nemours Children's Hospital

Orlando, FL United States
  Connect »

Johns Hopkins All Children's Hospital

Saint Petersburg, FL United States
  Connect »

Blank Children's Hospital

Des Moines, IA United States
  Connect »

Norton Children's Hospital

Louisville, KY United States
  Connect »

Children's Hospital New Orleans

New Orleans, LA United States
  Connect »

C S Mott Children's Hospital

Ann Arbor, MI United States
  Connect »

Geisinger Medical Center

Danville, PA United States
  Connect »

Cook Children's Medical Center

Fort Worth, TX United States
  Connect »

Seattle Children's Hospital

Seattle, WA United States
  Connect »

Primary Children's Hospital

Salt Lake City, UT United States
  Connect »

M D Anderson Cancer Center

Houston, TX United States
  Connect »

AdventHealth Orlando

Orlando, FL United States
  Connect »

Mission Hospital

Asheville, NC United States
  Connect »

Bronson Methodist Hospital

Kalamazoo, MI United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.